Homeopathy. 2016 Feb;105(1):119-25. doi: 10.1016/j.homp.2015.08.001. Epub 2015 Oct 1.
- 1Strasbourg
Oncologie Libérale, Supportive Care Unit, Clinique Sainte Anne, Groupe
Hospitalier Saint Vincent, F-67000 Strasbourg, France. Electronic address: jlbagot@orange.fr.
Abstract
BACKGROUND:
Chemotherapy,
hormone therapy, and new targeted therapies for cancer lead to adverse
effects which are often difficult to relieve using classical homeopathy.
Besides diminishing the quality of life of the patient, they can force
the oncologist to reduce or even to cease treatment prematurely, which
represents a loss of opportunity for the patient. Faced with these
recurring problems, would the use of homeopathic dilution of
chemotherapy, also called hetero-isotherapy, be a suitable response for
improving the tolerance of and the adherence to cancer treatment?
METHODS:
Based
on experiments conducted for over 50 years by many authors, we have
offered our patients, since 1998, a protocol of hetero-isotherapy
chemotherapy starting the day after each cytotoxic infusion. It involves
taking a daily dose of a dilution of the chemotherapy used, using the
increased dilution technique from 5c to 15c.
RESULTS:
We
observed a significant decrease in side effects, allergic reactions and
late sequelae in the more than 6000 hetero-isotherapic treatments given
to some 4000 patients. The better tolerance to chemotherapy and the
improvement in quality of life led to an increase in treatment
adherence. No interference with chemotherapy was observed. When it was
necessary to prescribe another homeopathic medicine, combination with
hetero-isotherapy generally improved its effectiveness.
CONCLUSION:
In
a large population, followed for over 15 years, we observed that
hetero-isotherapics, well tolerated and easy to use, reduced the side
effects of chemotherapy, targeted therapy or hormone therapy, and so
improve the quality of life of patients.
Copyright © 2015 The Faculty of Homeopathy. Published by Elsevier Ltd. All rights reserved.
KEYWORDS:
Adverse effects; Cancer; Hetero-isotherapy; Homeopathy; Supportive care
